Answer
Rhabdomyolysis has been reported during postmarketing use in patients taking ranolazine (Ranexa) and simvastatin together.
Sources for this answer
- Ranexa 375 mg Prolonged-release tabletA. Menarini Farmaceutica Internazionale SRL · emc · SmPC §4.5 Interaction with other medicinal products · Version 20Document updated
Sources checked